logo

Clinical Trial Calendar

Share
Company Name EYEGATE PHARMACEUTICALS INC
Event Name Topline data from confirmatory Phase 3 trial of EGP-437 combination product
Indication Non-infectious anterior uveitis;
Outcome Date
Outcome
Result Date Q4 2017
News
http://www.eyegatepharma.com/press-release/eyegate-pharmaceuticals-reports-full-year-2016-financial-results-and-provides-business-update/
Return to Clinical Trial Calendar